1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Yangshengtang Co., Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus Infection 162, Placebo - Chronic Hepatitis B Virus Infection | Phase 1 | Terminated | Yangshengtang Co., Ltd | 1 | 2024-06-03 | 2024-07-16 |
| Phase 1 Study of 162, a Novel Neutralizing Antibody Targeting Hepatitis B Surface Antigen, in Healthy Adult Subjects 162, Placebo - Chronic Hepatitis B | Phase 1 | Completed | Yangshengtang Co., Ltd | 20 | 2022-09-30 | 2023-11-27 |
Australia (2)